SUN PHARM INDUSTRIES Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDUSTRIES, and what generic alternatives to SUN PHARM INDUSTRIES drugs are available?
SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.
There is one US patent protecting SUN PHARM INDUSTRIES drugs. There are two tentative approvals on SUN PHARM INDUSTRIES drugs.
There are twenty-two patent family members on SUN PHARM INDUSTRIES drugs in eighteen countries and one hundred and twenty-seven supplementary protection certificates in sixteen countries.
Summary for SUN PHARM INDUSTRIES
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 100 |
| Ingredients: | 97 |
| NDAs: | 167 |
Drugs and US Patents for SUN PHARM INDUSTRIES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | METHADONE HYDROCHLORIDE | methadone hydrochloride | TABLET;ORAL | 208305-001 | Mar 30, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sun Pharm Industries | FLUOXETINE | fluoxetine hydrochloride | CAPSULE;ORAL | 075787-001 | Jan 29, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sun Pharm Industries | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 065134-001 | May 13, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;ORAL | 077288-002 | Apr 23, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sun Pharm Industries | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 075896-001 | Nov 2, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sun Pharm Industries | FOLIC ACID | folic acid | TABLET;ORAL | 040582-001 | Jul 18, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sun Pharm Industries | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091285-002 | Sep 12, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUN PHARM INDUSTRIES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Sign Up |
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Sign Up |
| Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Sign Up |
| Sun Pharm Industries | BACTRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUN PHARM INDUSTRIES Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Ukraine | 115073 | ⤷ Sign Up |
| European Patent Office | 2919753 | ⤷ Sign Up |
| South Africa | 201502692 | ⤷ Sign Up |
| Hong Kong | 1214154 | ⤷ Sign Up |
| Singapore | 11201502931Y | ⤷ Sign Up |
| Brazil | 112015008951 | ⤷ Sign Up |
| South Korea | 101832041 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for SUN PHARM INDUSTRIES Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0503785 | CA 2011 00026 | Denmark | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| 2498758 | 132020000000034 | Italy | ⤷ Sign Up | PRODUCT NAME: METFORMINA O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE; SAXAGLIPTIN O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE; DAPAGLIFLOZIN O UN SUO SOLVATO FARMACEUTICAMENTE ACCETTABILE.(QTRILMET); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1401, 20191113 |
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| 1261586 | 1290013-0 | Sweden | ⤷ Sign Up | PRODUCT NAME: SAXAGLIPTIN/METFORMIN; REG. NO/DATE: EU/1/11/731/001 20111124 |
| 1506211 | 132014902277722 | Italy | ⤷ Sign Up | PRODUCT NAME: UNA COMBINAZIONE DI DAPAGLIFLOZIN O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE E METFORMINA O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE COME PROTETTI DAL BREVETTO DI BASE EP1506211(XIGDUO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/900, 20140116 |
| 1532149 | C300569 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LINAGLIPTINE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN COMBINATIE MET METFORMINEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/12/780/001-028 20120720 |
| 1532149 | 132013902118390 | Italy | ⤷ Sign Up | PRODUCT NAME: LINAGLIPTIN + METFORMINA CLORIDRATO(JENTADUETO); AUTHORISATION NUMBER(S) AND DATE(S): DA EU/1/12/780/001 A EU/1/12/780/027, 20120720 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
